ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)

News

Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Zura Bio Reports Business Updates and Outlook for 2026
Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com